Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,914,065
+$1,359,154 QoQ
Shares Held
4,097
+6.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.99%
of 13F equity value
Holder Rank
#1,729
of 4,605 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Royal Capital Wealth Management, LLC holds $10,476,606 across 5 Drug Manufacturers - General names. LLY ranks #1 (46.9% of the industry book) .
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,914,065 | 4,097 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,554,911 | 3,865 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,157,937 | 3,869 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,959,677 | 3,879 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,832,812 | 3,634 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,001,356 | 3,634 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,805,448 | 3,634 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $3,206,216 | 3,619 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,502,915 | 3,869 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,861,336 | 3,678 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,861,846 | 3,194 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,715,593 | 3,194 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,497,922 | 3,194 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $923,456 | 2,689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $947,159 | 2,589 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $701,346 | 2,169 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $586,532 | 1,809 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $389,176 | 1,359 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||